Walgreens offloads more Cencora shares

The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10%.
The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10%.
The deal could signal that Elevance wants to build out its commercial products to hedge against volatility in Medicaid and privatized Medicare plans.
Bankrupt Prospect Medical Holdings scuttled a deal to sell Crozer Health but secured $20 million in funding from regulators to keep Crozer’s operations afloat for one more month.
Disruption to the supply of devices from China would curtail hospitals’ ability to perform life-saving surgeries and protect patients and healthcare workers from contagion, the group warned.
Christopher McGinnis is taking the reins as finance chief weeks after the prescription price transparency company also appointed a new CEO.
The CMS said it’s working to find “opportunities for more effective and efficient use of resources in line with meeting the goals of President Trump.” The agency could be a big — and politically delicate — target for DOGE.
Caroline Pearson, executive director of the Peterson Health Technology Institute, discusses the institute’s new task force that aims to study the financial, efficiency and workforce effects of AI products.
Medicaid and dual-eligible contracts fuel growth for the California-based insurer, but also come with upfront implementation costs that will lower its earnings this year, executives said.
Doctors groups signed on to lawsuits seeking to overturn policies that limit gender-affirming care for minors and remove some public-facing health information.
The two have mended fences after a nasty contract dispute in 2022 caused Kroger pharmacies to go out of network with Express Scripts’ members.